Lung Cancer
A topic on our watch list — we track its coverage across 9 domains, including Pubmed Targeted, Industry News and Preprint.
Coverage of Lung Cancer is holding steady : 7 signals on the latest tracked day, level with its three-week baseline of 7, across 4 domains. That makes it the #168 most-covered of the 348 concerns we track.
What’s changed
- Pan-RAS Inhibitor Shows Activity in Advanced Lung Cancer. · Cancer Discov · 2026-09-03
- A Comparative Analysis of the Economic Burden of Breast, Colorectal and Lung Cancer-Related Premature Mortality in Slovenia: Value-Added Decomposition by Occupation-Gender Groups. · Zdr Varst · 2026-09-01
- Pan-cancer single-cell atlas of immunotherapy response identifies ZNF385A as a regulator of immune evasion in small cell lung cancer. · Biochim Biophys Acta Mol Basis Dis · 2026-08-29
- One-pot SP-EXPAR-integrated CRISPR/Cas14a assay for highly specific and versatile detection of ctDNA mutations in lung cancer patients. · Anal Methods · 2026-08-24
- Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer. · Immunotherapy · 2026-08-24
- Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations - mskcc.org · Targeted Therapy Oncology (Google News) · 2026-09-02 · usually covers Targeted Therapy
What the reporting says
It shows up alongside KRAS (66 — acquisition ×3), Immunotherapy (39), Colorectal Cancer (31), Egfr (23 — acquisition ×2), G12d (15), ctDNA (13), FDA (27), Abstract (18).
Two steps out: Pancreatic Cancer (through KRAS, 49 shared stories on the weaker link); KRAS Mutant (through KRAS, 46 shared stories on the weaker link); MSI-H (through Immunotherapy, 39 shared stories on the weaker link); Braf (through Colorectal Cancer, 31 shared stories on the weaker link).
Tracked since Jan 1, with coverage on 60 separate days — concentrated in Oncology and Pubmed Targeted.